啟明醫療-B(02500.HK)擬回購不超10%股份
格隆匯12月6日丨堃博醫療-B(02216.HK)發佈公吿,公司董事會有意行使根據公司股東於2021年5月21日舉行的公司2020年度股東大會、2021年第一次H股類別股東會議及2021年第一次非上市外資股類別股東會議上通過的決議案授予董事會的一般授權項下的權力,以購回公司H股股份,即不超過於年度股東大會及類別會議通過特別決議案當日已發行H股股份總數的10%,實施期限為年度股東大會授權期限屆滿之前。
於2021年12月6日,董事會已決定動用股份購回授權,並根據市況不時於公開市場購回H股股份,以使用最多2.5億港元的資金進行建議股份購回。購回的H股股份應予以註銷。董事會相信,於目前情況下進行股份購回説明公司對自身業務前景及展望的信心,並將最終令公司受惠及為股東創造價值。董事會相信,公司目前的財務資源將使其能夠實施建議股份購回,同時維持穩健的財務狀況。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.